Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AXON ENTERPRISE, INC.AXON · Entity 567 | Director | May 29, 2025 | June 02, 2025 |
| Heartflow, Inc.HTFL · Entity 3993 | Director | June 16, 2026 | June 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AXON ENTERPRISE, INC.
Report date May 29, 2025 · Filed June 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,181 |
Reported balance
After 2025-05-29 transaction · row 1
1 source rowRow 1 · 2025-05-29 · Grant · Acquired 446 · Balance 2,181 F1: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2026 Annual Meeting of Shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2026 Annual Meeting of Shareholders.
Heartflow, Inc.
Report date June 16, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $32.05 · Expires 2036-06-16 | Direct | 16,075 |
Reported balance
After 2026-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 16,075 · Balance 16,075 F1: The option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Astra Space, Inc.
Report date July 18, 2024 · Filed July 19, 2024
Section 16 reporting ended · disclosed 2024-07-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-07-18 transaction · row 1
1 source rowRow 1 · 2024-07-18 · Other · Disposed 28,504 · Balance 0 F1: On July 18, 2024, Apogee Parent, Inc. ("Parent") acquired the issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the issuer, Parent and Apogee Merger Sub, a direct, wholly owned subsidiary of Parent ("Merger Sub"), dated as of March 7, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the issuer, with the issuer surviving such merger as a wholly owned subsidiary of Parent (the "Merger"). F2: Reflects shares of Class A Common Stock of the issuer that, pursuant to the Merger Agreement and in connection with the consummation of the Merger, were automatically canceled and converted into the right to receive $0.50 per share in cash, without interest. |
Filing footnotes · ownership attribution and instrument terms
F1: On July 18, 2024, Apogee Parent, Inc. ("Parent") acquired the issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the issuer, Parent and Apogee Merger Sub, a direct, wholly owned subsidiary of Parent ("Merger Sub"), dated as of March 7, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the issuer, with the issuer surviving such merger as a wholly owned subsidiary of Parent (the "Merger").
F2: Reflects shares of Class A Common Stock of the issuer that, pursuant to the Merger Agreement and in connection with the consummation of the Merger, were automatically canceled and converted into the right to receive $0.50 per share in cash, without interest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 18, 2026 21:30 UTC | Heartflow, Inc. HTFL · Entity 3993 | GrantStock Option · Derivative | 16,075 | $32.05 Strike: $32.05 | $515,203.75 |
DisclosureSEC source: 0001464521-26-000091 · form4.xml · derivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,075 Underlying: Common Stock · 16,075 shares Expires 2036-06-16 F1 · derivative.exercise_date: The option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date. Read SEC document |
| March 05, 2026 Filed Mar 7, 2026 01:18 UTC | Heartflow, Inc. HTFL · Entity 3993 | SaleCommon Stock | 9,122 | $25.00 | $228,050.00 |
DisclosureSEC source: 0001464521-26-000024 · form4.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,291 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. Read SEC document |
| February 05, 2026 Filed Feb 7, 2026 02:42 UTC | Heartflow, Inc. HTFL · Entity 3993 | SaleCommon Stock | 8,000 | $27.32 | $218,560.00 |
DisclosureSEC source: 0001464521-26-000008 · form4.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,413 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. Read SEC document |
| August 07, 2025 Filed Aug 12, 2025 01:01 UTC | Heartflow, Inc. HTFL · Entity 3993 | GrantStock Option · Derivative | 23,710 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001628280-25-039738 · wk-form4_1754960493.xml · derivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,710 Underlying: Common Stock · 23,710 shares Expires 2035-08-07 F1 · derivative.exercise_date: The option will vest in full on the earlier of Heartflow, Inc.'s annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:55 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | GrantCommon Stock | 446 | $0.00 | $0.00 |
DisclosureSEC source: 0001069183-25-000137 · wk-form4_1748904937.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,181 F1 · shares: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2026 Annual Meeting of Shareholders. Read SEC document |
| May 12, 2025 Filed May 13, 2025 21:31 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 657 | $700.00 | $459,900.00 |
DisclosureSEC source: 0001069183-25-000094 · wk-form4_1747171890.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,735 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2024. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 22:09 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 1,261 | $682.06 | $860,077.16 |
DisclosureSEC source: 0001415889-24-028415 · form4-12052024_101239.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,392 F1 · price: The transaction was executed in multiple trades at prices ranging from $681.875 to $682.535. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 05, 2024 Filed Sep 6, 2024 20:38 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 900 | $353.53 | $318,177.00 |
DisclosureSEC source: 0001415889-24-023022 · form4-09062024_080951.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,653 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2024. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 18:39 UTC | Astra Space, Inc. ASTR · Entity 88837 | OtherClass A Common Stock | 28,504 | $0.50 | $14,252.00 |
DisclosureSEC source: 0001814329-24-000014 · primary_doc.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: On July 18, 2024, Apogee Parent, Inc. ("Parent") acquired the issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the issuer, Parent and Apogee Merger Sub, a direct, wholly owned subsidiary of Parent ("Merger Sub"), dated as of March 7, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the issuer, with the issuer surviving such merger as a wholly owned subsidiary of Parent (the "Merger"). F2 · shares: Reflects shares of Class A Common Stock of the issuer that, pursuant to the Merger Agreement and in connection with the consummation of the Merger, were automatically canceled and converted into the right to receive $0.50 per share in cash, without interest. Read SEC document |
| May 31, 2024 Filed Jun 3, 2024 23:23 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 993 | $281.72 | $279,747.96 |
DisclosureSEC source: 0001415889-24-015219 · form4-06032024_110649.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,553 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2023. Read SEC document |
| May 28, 2024 Filed May 29, 2024 20:37 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 478 | $286.04 | $136,727.12 |
DisclosureSEC source: 0001415889-24-014767 · form4-05292024_080555.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,546 Read SEC document |
| May 10, 2024 Filed May 13, 2024 22:16 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | GrantCommon Stock | 657 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-013054 · form4-05132024_100509.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,024 F1 · shares: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2025 Annual Meeting of Shareholders. Read SEC document |
| September 11, 2023 Filed Sep 13, 2023 00:16 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 515 | $214.47 | $110,452.05 |
DisclosureSEC source: 0001415889-23-013193 · form4-09132023_120947.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,367 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2023. Read SEC document |
| July 20, 2023 Filed Jul 24, 2023 20:34 UTC | Astra Space, Inc. ASTR · Entity 88837 | GrantClass A Common Stock | 386,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001814329-23-000013 · primary_doc.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 427,554 F1 · shares: On the transaction date, the reporting person received a grant of restricted stock units ("RSUs") under the Astra Space, Inc. 2021 Omnibus Incentive Plan in connection with service on the board of directors of Astra Space, Inc. (the "Company"). The RSUs fully vest in one installment on May 15, 2024. F2 · price: Each RSU is equivalent in value to one share of Class A common stock, par value $0.0001 per share, of the Company. Read SEC document |
| May 30, 2023 Filed May 31, 2023 21:03 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 1,180 | $196.00 | $231,280.00 |
DisclosureSEC source: 0001415889-23-008973 · form4-05312023_090515.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,882 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. Read SEC document |
| May 22, 2023 Filed May 23, 2023 21:38 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 2,013 | $197.58 | $397,728.54 |
DisclosureSEC source: 0001415889-23-008640 · form4-05232023_090532.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,062 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. Read SEC document |
| May 12, 2023 Filed May 16, 2023 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | GrantCommon Stock | 993 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008067 · form4-05162023_120511.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,075 F1 · shares: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. 2022 Stock Incentive Plan. The grant is scheduled to vest on May 13, 2024. Read SEC document |
| March 16, 2023 Filed Apr 10, 2023 18:54 UTC | Astra Space, Inc. ASTR · Entity 88837 | GrantClass A Common Stock | 40,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001814329-23-000006 · primary_doc.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,650 F1 · shares: On the transaction date, the reporting person received a grant of restricted stock units ("RSUs") under the Astra Space, Inc. 2021 Omnibus Incentive Plan in connection with service on the board of directors of Astra Space, Inc. (the "Company"). The RSUs fully vest in one installment on May 15, 2023. F2 · price: Each RSU is equivalent in value to one share of Class A common stock, par value $0.0001 per share, of the Company. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 20:05 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 1,502 | $102.14 | $153,414.28 |
DisclosureSEC source: 0001415889-22-005955 · form4-06012022_010623.xml · nonDerivative · entry 2 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,082 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:05 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 478 | $99.91 | $47,756.98 |
DisclosureSEC source: 0001415889-22-005955 · form4-06012022_010623.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,584 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. Read SEC document |
| May 20, 2022 Filed May 23, 2022 23:09 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | GrantCommon Stock | 2,013 | $99.40 | $200,092.20 |
DisclosureSEC source: 0001415889-22-005543 · form4-05232022_040529.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,062 F1 · shares: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. 2019 Stock Incentive Plan. The grant is scheduled to vest on May 20, 2023. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 17:05 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 290 | $141.06 | $40,906.82 |
DisclosureSEC source: 0001415889-21-002813 · form4-06042021_010601.xml · nonDerivative · entry 3 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,049 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. F4 · price: The transaction was executed in multiple trades at prices ranging from $140.82 to $141.655. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 17:05 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 164 | $139.99 | $22,958.03 |
DisclosureSEC source: 0001415889-21-002813 · form4-06042021_010601.xml · nonDerivative · entry 2 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,339 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $139.53 to $140.21. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 17:05 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 209 | $138.59 | $28,965.73 |
DisclosureSEC source: 0001415889-21-002813 · form4-06042021_010601.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,503 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $138.22 to $139.21. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:05 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 14 | $141.40 | $1,979.60 |
DisclosureSEC source: 0001415889-21-002762 · form4-06022021_040601.xml · nonDerivative · entry 4 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,712 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:05 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 112 | $139.44 | $15,617.62 |
DisclosureSEC source: 0001415889-21-002762 · form4-06022021_040601.xml · nonDerivative · entry 3 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,726 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. F4 · price: The transaction was executed in multiple trades at prices ranging from $139.15 to $139.685. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:05 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 118 | $138.28 | $16,317.16 |
DisclosureSEC source: 0001415889-21-002762 · form4-06022021_040601.xml · nonDerivative · entry 2 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,838 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $137.93 to $138.915. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:05 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 37 | $137.20 | $5,076.55 |
DisclosureSEC source: 0001415889-21-002762 · form4-06022021_040601.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,956 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $136.825 to $137.345. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 20:06 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | GrantCommon Stock | 1,434 | $139.48 | $200,014.32 |
DisclosureSEC source: 0001415889-21-002727 · form4-06012021_040637.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,993 F1 · shares: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. 2019 Stock Incentive Plan. The grant is scheduled to vest in three equal installments beginning on May 27, 2022. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 20:30 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | SaleCommon Stock | 661 | $85.59 | $56,572.35 |
DisclosureSEC source: 0001415889-20-002190 · form4-08282020_040802.xml · nonDerivative · entry 2 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,559 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $85.295 to $86.015. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 20:30 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | SaleCommon Stock | 198 | $84.75 | $16,780.50 |
DisclosureSEC source: 0001415889-20-002190 · form4-08282020_040802.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,220 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $84.26 to $85.09. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 20:30 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | SaleCommon Stock | 3 | $93.94 | $281.82 |
DisclosureSEC source: 0001415889-20-001943 · form4-07222020_040701.xml · nonDerivative · entry 2 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,418 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $93.55 to $94.14. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 20:30 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | SaleCommon Stock | 837 | $93.13 | $77,946.46 |
DisclosureSEC source: 0001415889-20-001943 · form4-07222020_040701.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,421 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $92.54 to $93.51. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 02, 2020 Filed Jun 2, 2020 22:10 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | SaleCommon Stock | 46 | $98.48 | $4,530.08 |
DisclosureSEC source: 0001415889-20-001442 · form4-06022020_060606.xml · nonDerivative · entry 6 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,258 F2 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. Read SEC document |
| June 02, 2020 Filed Jun 2, 2020 22:10 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | SaleCommon Stock | 173 | $97.30 | $16,832.90 |
DisclosureSEC source: 0001415889-20-001442 · form4-06022020_060606.xml · nonDerivative · entry 5 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,304 F2 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. F5 · price: The transaction was executed in multiple trades at prices ranging from $97.02 to $97.60. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 02, 2020 Filed Jun 2, 2020 22:10 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | SaleCommon Stock | 127 | $95.78 | $12,164.06 |
DisclosureSEC source: 0001415889-20-001442 · form4-06022020_060606.xml · nonDerivative · entry 4 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,477 F2 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. F4 · price: The transaction was executed in multiple trades at prices ranging from $95.515 to $95.97. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 02, 2020 Filed Jun 2, 2020 22:10 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | SaleCommon Stock | 316 | $94.77 | $29,947.64 |
DisclosureSEC source: 0001415889-20-001442 · form4-06022020_060606.xml · nonDerivative · entry 3 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,604 F2 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $94.245 to $95.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 02, 2020 Filed Jun 2, 2020 22:10 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | SaleCommon Stock | 2 | $91.80 | $183.60 |
DisclosureSEC source: 0001415889-20-001442 · form4-06022020_060606.xml · nonDerivative · entry 2 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,920 F2 · kind: This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 22:10 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | GrantCommon Stock | 2,107 | $75.96 | $160,047.72 |
DisclosureSEC source: 0001415889-20-001442 · form4-06022020_060606.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,922 F1 · shares: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. 2019 Stock Incentive Plan. The grant is scheduled to vest in three equal installments beginning on May 29, 2021. Read SEC document |
| August 14, 2019 Filed Aug 15, 2019 20:45 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | SaleCommon Stock | 1,360 | $57.86 | $78,682.80 |
DisclosureSEC source: 0001069183-19-000105 · wf-form4_156590193680831.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,815 F1 · kind: Securities disposed represent securities sold on the open market to settle the reporting person's tax liability incident to the vesting of restricted stock units. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 22:18 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | GrantCommon Stock | 2,396 | $66.78 | $160,004.88 |
DisclosureSEC source: 0001069183-19-000090 · wf-form4_155960030154993.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,175 F1 · shares: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. 2019 Stock Incentive Plan. The grant is scheduled to vest in three equal installments beginning on May 31, 2020. Read SEC document |
| July 19, 2018 Filed Jul 23, 2018 21:20 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | SaleCommon Stock | 2,100 | $72.79 | $152,859.00 |
DisclosureSEC source: 0001069183-18-000081 · wf-form4_153238081147529.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,779 F1 · kind: This sale of vested restricted stock units was executed pursuant to a filed 10b5-1 plan. Read SEC document |
| May 24, 2018 Filed May 24, 2018 22:45 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | GrantCommon Stock | 2,577 | $62.08 | $159,980.16 |
DisclosureSEC source: 0001069183-18-000068 · wf-form4_152720192212131.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,879 Read SEC document |
| July 19, 2017 Filed Jul 31, 2017 15:46 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | GrantCommon Stock | 6,302 | $25.39 | $160,007.78 |
DisclosureSEC source: 0001069183-17-000109 · wf-form4_150151600491774.xml · nonDerivative · entry 1 Cullivan Julie A · CIK 0001713207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,302 F1 · shares: Time-vested restricted stock units granted to the reporting person pursuant to the TASER International, Inc. 2016 Stock Incentive Plan. The grant is scheduled to vest in three equal annual installments beginning on July 19, 2018 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.